1165 København K
Tlf: 21 17 95 65 (man-fre kl. 9-15)
Ph.d.-forsvar — Lisbeth Liliendal Valbjørn Møller is defending her PhD thesis: Novel molecular mechanisms in Rho GTPase-mediated regulation of muscle mass and insulin sensitivity: The role of RhoGDIα and group I PAKs
Date & Time:
Department of Nutrition, Exercise and Sports
10 June 2020, 14:00
Associate professor Faidon Magkos (chair), Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark.
Professor Anna Krook, Karolinska Institute, Sweden
Professor Markus Rüegg, Basel University, Switzerland
Professor Erik Richter, Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark.
Assistant professor Lykke Sylow, Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark.
About the thesis
Skeletal muscles are critical for whole-body glycemic control and crucial for maintaining an independent lifestyle. The loss of muscle mass is common in several pathological conditions that are associated with a reduced ability of insulin to increase muscle glucose uptake. Thus, understanding the molecular mechanisms underlying this phenomenon is vital.
In addition to insulin, muscle contraction also increases muscle glucose uptake. The Rho family GTPase, Rac1 is highly important for glucose uptake in response to both insulin and muscle contraction. However, how Rac1 is activated and regulate glucose uptake is incompletely understood.
The present PhD thesis aimed to identify novel molecules that interact with Rac1 in muscle. It was discovered that inactive Rac1 interacted with a protein called RhoGDIα. RhoGDIα is an inhibitor of Rho GTPases.
Accordingly, the importance of RhoGDIα in the regulation of Rac1 activity and muscle glucose uptake in response to insulin was investigated. Rac1 activates a group of molecules called group I PAKs. Thus, additionally, the importance of group I PAKs for muscle glucose uptake in response to both insulin and muscle contraction was explored.
The present PhD thesis demonstrates that RhoGDIα is an inhibitor of Rac1 in skeletal muscle cells. Furthermore, increased expression or depletion of RhoGDIα in muscle identified RhoGDIα as a negative regulator of muscle glucose uptake in response to insulin. Increased muscle RhoGDIα expression also impaired glucose tolerance at a whole-body level in mice.
Thus, the observed increase in RhoGDIα expression in muscle from type 2 diabetic subjects could potentially explain the previously reported dysfunctional Rho GTPases in these subjects in response to insulin.
Interestingly, it was found that RhoGDIα is also important for muscle mass. Lastly, glucose uptake in response to insulin and muscle contractions was found to partly depend on PAK2, but not PAK1, in mouse muscle.
In conclusion, RhoGDIα is identified as a novel regulator of muscle mass and insulin sensitivity and evidence is provided that Rac1-mediated glucose uptake partly depends on PAK2, but not PAK1.